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disease with the MAGE expression profile in primary tumor
tissue, venous blood, and bone marrow aspirates of cancer
patients in several cohorts. Subsequently, a detailed statistical
assessment of the data sets has to be done, and the proposed
method for summarizing the patterns of MAGE expression may
be helpful for the generation of a later decision model. However,
far more clinical experience is needed with this approach, and
quantitative data will have to be included in the final analysis as
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We read with interest the article by Choi et al1 (November
2004) concerning the incidence and risk factors of delayed
pneumothorax after transthoracic fine-needle aspiration (FNA)
of pulmonary lesions guided by a variety of radiologic techniques.
The article is both well written and informative. As the authors
indicate in their discussion, it is a common practice to obtain a
chest radiograph typically 4 h after percutaneous transthoracic
needle aspiration.2
The incidences of early and delayed pneumothorax in the study
by Choi et al were 18.6% and 3.3%, respectively. However, all of
the patients in their study who required tube thoracostomy for
delayed pneumothorax were symptomatic. This represents  1%
of their study population. Interestingly, none of the patients in
this study with delayed pneumothorax had undergone CT-guided
FNA. We have previously reported that immediate pneumotho-
rax develops in 17.2 to 24.1% of patients undergoing CT-guided
FNA.3,4 In our studies, delayed pneumothorax occurs in 2.5 to
3.1% of patients who underwent this procedure. Moreover,
delayed pneumothorax requiring intervention with pleural space
evacuation occurred in 1.3 to 1.6% of patients.
While we agree the conclusion of Choi et al that late pneumo-
thorax is clinically important, the practice of obtaining a delayed
postprocedure chest radiograph after CT-guided FNA does not
appear to be an efficient use of resources. Based on our research,
chest radiography appears to add little information regarding
lung expansion to that obtained by CT at the end of CT-guided
FNA. Instruction to seek medical attention in the event of
symptoms of pneumothorax appears be a more effective method
of addressing this potential complication.
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To the Editor:
In our study (November 2004),1 most transthoracic needle
biopsies were performed by fluoroscopic and ultrasonography
guidance. Only 4.5% of the transthoracic needle biopsies (21 of
458) were performed with CT scan guidance. Therefore, it is
difficult to compare our data to the data of Byrd et al2 and
Shantaveerappa et al.3
Definitely, CT scanning is more sensitive than a posteroante-
rior chest radiograph for the detection of pneumothorax. After
the analysis of our data, we had a suspicion that a delayed
pneumothorax was simply so small and localized that it would go
undetected by a posteroanterior chest radiograph at 4 h but
would be detectable by CT scan if one were performed.
However, according to his previous work, delayed pneumotho-
rax still occurred in 4 of 158 patients (2.53%) even though a CT
scan was performed after the CT scan/fine-needle aspiration.3
This rate is not so different from that in our study1 (3.3%; 15 of
458). The study by Shantaveerappa et al3 helps us to resolve our
suspicion. Furthermore, the rate of intervention was even higher
(all patients, 1.7% [2 of 158]; patients with delayed pneumotho-
rax, 50% [2 of 4]) in their study3 than that in ours (all patients,
0.65% [3 of 458]; patients with delayed pneumothorax, 20% [3 of
15]).1 I think that the two studies showed quite similar data but
different interpretations.
Choon-Taek Lee, MD, PhD
Seoul National University Bundang Hospital
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We read with interest the article by Hegab et al.1 Although
interleukin (IL)-1 is also thought to be one of the important
cytokines in COPD, Joos et al2 failed to show the relationship
between functional single nucleotide polymorphisms at the
IL-1 promotor gene at position 511. However, since their
reports were published, there was an explosion of reports
revealing the association between IL-1 511 polymorphisms
and a variety of diseases ranging from psychological3 to dental
disease.4 Therefore, completely healthy elderly people were
recruited from a large health survey in the Sendai area.
To elucidate the genotype of IL-1 polymorphisms at
positions 31 and 511, polymerase chain reaction and
restriction enzyme fragment length polymorphisms were per-
formed on blood samples.2,3 Table 1 shows the characteristics
of 85 COPD patients and 68 healthy subjects and the distri-
bution of IL-1 511 and 31 genotypes in these two groups.
The T allele at 511 SNP (p  0.02) was overrepresented in
the healthy control subjects. The homozygote subjects were
particularly at lower risk for COPD, with an odds ratio of 0.43
for 511 C/C and T/C. Although IL-1 31 and 511 loci
had linkage disequilibrium, there were no differences on the C
allele 31 and genotyped frequency of IL-1 between the
COPD patients and the control subjects.
Different from the report Joos et al,2 we showed a signifi-
cant association between only the T allele at 511 SNP and
susceptibility to COPD. First, because both the COPD pa-
tients and the control subjects were elderly, we suspect that
the IL-1 511 loci strongly affects susceptibility to COPD
with chronic inflammation for a long time. Second, since there
is much evidence linking IL-1 511 polymorphisms and
other diseases,3–5 healthy elderly smokers who have not had
these diseases may have the T allele at 511 SNP. Since there
were no differences in the distribution of IL-1 polymor-
phisms at position 31 between the COPD patients and the
control subjects, we believe that our sample size was not large
enough to detect small differences between the two groups.













Age, yr 65.6  10.6 66  8.6 0.80
Pack-years 44  17 47  14 0.67
Gender
Male 66 (97.1) 82 (95.3)
Female 2 (2.9) 3 (4.7) 0.83
Pulmonary function
FVC (% of predicted) 98  5 84  7 0.11
FEV1/FVC, % 95  5 47  2 0.01
IL-1 -511 (T-C)
Genotypes
T/T 25 (36.8) 17 (20.0) 0.02 0.43 0.20–0.89
T/C 29 (42.6) 42 (49.4) 0.40 1.31 0.69–2.50
C/C 14 (20.6) 26 (30.6) 0.16 1.70 0.80–3.59
Alleles
C 57 (41.9) 94 (55.3)
T 79 (58.1) 76 (44.7) 0.02 0.58 0.37–0.92
IL-1 -31 (T-C)
Genotypes
C/C 20 (29.4) 20 (23.5) 0.41 0.74 0.36–1.52
T/C 32 (47.1) 40 (47.1) 0.79 0.92 0.48–1.75
T/T 16 (23.5) 25 (29.4) 0.41 1.35 0.65–2.81
Alleles
C 72 (52.9) 80 (47.1)
T 64 (47.1) 90 (52.9) 0.31 1.27 0.81–1.99
*Data are presented as mean  SEM or No. (%) unless otherwise indicated.
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